SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 31.03+0.1%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Robert S. who wrote (7939)12/4/1998 2:57:00 PM
From: Robert K.  Read Replies (3) of 17367
 
Right on Robert S.> Your comment>These issues remain a
matter of considerable controversy>if the microbial toxins targeted by BPI are responsible
for sepsis and if neutralization and/or attenuation
of same is beneficial to a patient.<END Robert S Comment.
(sentences reversed, but idea is same)

Now let me get this strait, you are saying that bacteria produce toxins
and you are saying that neutralization or attenuation of these toxins
may not be beneficial. In fact, you are saying that this is a matter of
>CONSIDERABLE< controversy. OK dude, whatever you say.
I wonder what Girior or Opal or and other DR would say about that!
Geez, elimination of a foreign toxin is not helpful.>>>>>>Pleeease..
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News